The QualityStocks Daily Newsletter for Wednesday, April 28th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Wall Street Resources (HSTH)


Penny Trader (WLSI)


Penny To Buck (PWRM)

The QualityStocks Daily

Positron Corp. (POSC)

Market Wrap Daily, Stock Traders Chat, Stockpalooza, Stock Source, Bestotc.com, MicrocapVoice, Penny Invest, HotOTC.com, Cool Penny Stocks, and Stock Rich all reported recently on Positron Corp. (POSC), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Positron Corp. is a molecular imaging company that focuses on Nuclear Cardiology. The Company uses their proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Founded in 1983, Positron Corp. has their headquarters in Fishers, Indiana.

The Company maintains associations and relationships with multiple industry associations. These include the Academy of Molecular Imaging, American College of Cardiology, American Society of Nuclear Cardiology, and Society of Nuclear Medicine. Positron Corp. is a leading player in the cardiac imaging industry.

The Company's products include the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device, and the Tech-Assist™, a radiopharmaceutical injection shield. Physicians use Positron's systems as diagnostic and treatment evaluation tools. They use them in the areas of cardiology, neurology, and oncology. The Company markets their equipment and services through sales personnel and distributors.

Yesterday, Positron announced that their CEO Patrick G. Rooney and senior executives will present at the NASDAQ MarketSite in Times Square, New York City, New York. They will introduce business initiatives and certain strategic alliances with industry leading companies. They will address how certain opportunities will affect the industry and the Company. The presentation will take place on May 5, 2010, at 1:00 pm EDT, at the NASDAQ MarketSite, 4 Times Square, in New York City.

Today, Patrick G. Rooney confirmed in an interview with BioMedReports that his Company is about to grow significantly given various new partnerships and shifting market conditions. During the last three months alone, requests for proposals at Positron Corp. have increased three-fold, according to Mr. Rooney.
Positron recently won the 2010 Frost and Sullivan "North American Molecular Imaging Systems New Product Innovation Award." Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance. This is in areas such as leadership, technological innovation, customer service, and strategic product development. Positron received the 2010 Frost & Sullivan Award for New Product Innovation in the cardiac molecular imaging systems market.

Positron Corp. (POSC) closed today at $0.23 up 43.75 percent. Volume was 25,172,461.

Nuinsco Resources Limited (NWI.TO)

Today we are highlighting Nuinsco Resources Limited (NWI.TO), here at the QualityStocks Daily Newsletter.

Nuinsco Resources Limited is a growth-oriented, multi-commodity mineral exploration and development company. Trading on the Toronto Stock Exchange, the Company focuses on uranium, copper, zinc, and gold exploration and development in world-class mineralized belts in Canada, Turkey and Egypt. The Company has their headquarters in Toronto, Ontario.

Nuinsco also owns approximately 9 percent of the outstanding common shares of Gold Hawk Resources Inc. and approximately 2 percent of the outstanding common shares of Victory Nickel Inc., in addition to their property holdings. They also have a 10 percent royalty interest in, and a 50 percent interest in future cash flows from, Campbell's Corner Bay copper deposit in Quebec.

The Company's strategy for growth is to create pure-play resource companies to develop and bring into production existing projects in the pipeline. They also work to acquire and develop advanced projects with near-term production and cash flow potential. In addition, they look to identify technically superior exploration projects in solid regions, regardless of commodity.

In late March of this year, Nuinsco Resources announced that a field crew recently completed the initial phase of exploration at the Diabase Peninsula uranium property in the Athabasca Basin of northern Saskatchewan. This is as part of the Company's exploration program for 2010. The 21,900ha Diabase Peninsula property is on the western shore of Cree Lake approximately 5 kilometers north of the southern boundary of the Athabasca Basin. Nuinsco holds an approximate 83 percent interest in the property and is the operator, and they are partnered with Trend Mining Company of Denver, Colorado.

On April 20, 2010, further to their press releases of December 23, 2009, and March 5, 2010, Nuinsco Resources Limited announced that they completed the sale of their interests in the Cameron Lake Gold Project to a wholly owned subsidiary of Coventry Resources Limited. Nuinsco received total consideration of approximately $12 million consisting of cash, Coventry shares, and a 3 percent net smelter return royalty on the Cameron Lake Gold Project.

Nuinsco Resources Limited (NWI.TO) closed Wednesday's session at $0.0750 for no change. Volume was 35,000.

Innovative Designs Inc. (IVDN)

We are highlighting Innovative Designs Inc. (IVDN), here at the QualityStocks Daily Newsletter.

Innovative Designs, Inc. manufactures the Arctic Armor™ Line, hunting apparel, swimwear, wind shirts, jackets, and the multi-function "All in One", under the "i.d.i.gear" label featuring Insultex™. This Insultex™ is an ultra thin, light, and warm insulator that the Company utilizes. Innovative Designs Inc. has their corporate headquarters in Pittsburgh, Pennsylvania. Founded in 2002, the Company trades on the OTCBB.

Each Arctic Armor™ suit utilizes three layers of the Company's exclusive thermal insulator Insultex™. One layer of Insultex™ protects a person to sub-zero temperatures. Multiple layers of Insultex™ can provide almost unlimited levels of insulation. Insultex™ is also windproof, waterproof, and buoyant. Innovative Designs perfected the design under the strictest guidelines to ensure buoyancy. The Arctic Armor™ suit, with Insultex™, consists of micro-air molecules trapped inside the fabric to enhance buoyancy.

Insultex™ is the Company's new thermal insulation on the market. It is suitable for use in outerwear, gloves, hats, pants, tents, sleeping bags, coolers, boots, swimsuits, blankets, and comforters. It is suited to almost anything that would benefit from insulating or buoyant qualities.

Innovative Designs markets their products through distributors, sporting goods catalogs, trade shows, and retail outlets and chains. They also market through their Web portal, www.idigear.com. The Company markets in the United States, Canada, the Russian Federation, and Finland.

Last week, the Company announced that their retail presence continues to expand in Alaska. This is with the recent addition of Three Bears Alaska Inc. They have received and sent opening orders to locations in Wasilla, Palmer and Kenai, Alaska.

Today, Innovative Designs Inc. announced that they have completed the testing phase for their Insultex® House-Wrap. Testing took place at two facilities, one in British Columbia, and the other in Rhode Island.

Joseph Riccelli, CEO of Innovative Designs Inc., stated, "We have been working diligently with our product development team to conduct all testing necessary on our Insultex® House-Wrap. The results are in, substantiating what we have believed all along; we have a quality product, which has the potential to revolutionize the building industry. We are now finalizing our Marketing and Sales plans. Insultex® House-Wrap will be available in the very near future."

Innovative Designs Inc. (IVDN) closed Wednesday's session at $0.37 up 27.59 percent. Volume was 51,319.


Greenbackers reported yesterday on VIVUS Inc. (VVUS), Momentum Traders, Small Cap Network, DrStockPick.com, Momentum Trades, SpeculatingStocks.com, Gusher Stocks, and Wall Street News Alert did earlier. SmallCapInvestor.com, Hit and Run Candle Sticks, The Street, and Street Insider did as well, and we highlight the Company, here at the QualityStocks Daily Newsletter.

VIVUS Inc. is a biopharmaceutical company that trades on the NASDAQ Global Market. They focus on developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health. Founded in 1991, VIVUS Inc. has their corporate headquarters in Mountain View, California.

The Company's lead product in clinical development is Qnexa®. It has completed phase 3 clinical trials for the treatment of obesity. An NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. Qnexa is also in phase 2 clinical developments for the treatment of type 2 diabetes and obstructive sleep apnea.

In the area of sexual health, VIVUS is in phase 3 development with avanafil. This is a potentially best-in-class PDE5 inhibitor for the treatment of erectile dysfunction (ED). MUSE® (alprostadil) is already on the market and generating revenue for VIVUS Inc. It is a first generation therapy for the treatment of ED.

Yesterday, the Company announced that they would report their financial results for the first quarter ended March 31, 2010 after the NASDAQ Market closes on Monday, May 3, 2010. They will conduct a conference call and an audio webcast at 1:30pm PT on the same day.

Today, VIVUS, Inc. announced that data on Qnexa® would be presented at the American Society of Hypertension 25th Annual Scientific Meeting and Exposition in New York City. Qnexa® is an investigational drug candidate. The presentation will take place at the New York Hilton Hotel & Towers on Tuesday, May 4, 2010, 7:45-9:45 AM.

Suzanne Oparil, MD, professor of medicine, physiology and biophysics and director, vascular biology and hypertension program, division of cardiovascular disease, department of medicine at the University of Alabama at Birmingham, will make an oral presentation during the late-breaking clinical trials session. The title of the presentation is "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Blood Pressure and Results in Weight Loss in Overweight/Obese Patients Through 28 Weeks."

VIVUS Inc. (VVUS) closed Wednesday's trading at $9.69 up 1.36 percent. Volume was 4,551,018.

US Dataworks Inc. (UDW)

Today we choose to highlight US Dataworks Inc. (UDW), here at the QualityStocks Daily Newsletter.

US Dataworks Inc. is a leader in delivering enterprise payments solutions to financial institutions, businesses, and government entities. From electronic check conversion, distributed capture, or end-to-end payments processing, the Company provides the framework for doing it at an enterprise level, with industry-leading efficiency, flexibility, and scalability. US Dataworks Inc. trades on the NYSE Amex. They have their headquarters in Sugar Land, Texas.

The Company's flagship solution is Clearingworks. It is the industry's first deployed enterprise payments platform for the end-to-end processing of any paper-based or electronic payments or clearing channel. The Clearingworks platform provides modular capabilities for Payment Processing, Retail Processing, Check Processing, Payment Decisioning, and Returns Processing. Clearingworks integrates with any legacy payment systems, processes, and protocols.

On Monday of this week, US Dataworks announced the availability of ClearHistory®. ClearHistory currently features two modules. These are Payment Archive and Payment Analyzer.

Their ClearHistory is a suite of solutions that streamline the storage, management, and reporting of information from any payments processing or clearing channel. It extends the business benefits of the Company's Clearingworks enterprise payments platform.

ClearHistory combines substantial scalability and long-term information retention capabilities with integrated high-speed search, retrieval, and reporting. It contributes to reducing operations costs and streamlines compliance.  ClearHistory is the only platform that enables consolidation of data and images from any payment channel into a single, centrally managed solution. It leverages next generation data warehousing and management technology.

ClearHistory Payment Archive optimizes the management of information from any payment channel. It reduces costs and eliminates data silos, while meeting compliance and reporting requirements. The design of this highly flexible archive solution is for managing payments information across an enterprise. ClearHistory Payment Archive integrates with the Clearingworks enterprise payments platform.

ClearHistory Payment Analyzer is a first-of-its-kind solution that provides robust, user-configurable data analytics across all payment processing and clearing channels. ClearHistory Payment Analyzer's charts, graphs and data can undergo use to quickly evaluate trends during a processing day, and trends by day of the week, month-to-month, year-to-year and more. It can drive reporting, audits, CRM, operator statistics, and forecasting.

The Company has a contracted purchase of the solution and will be showcasing ClearHistory along with Clearingworks® enterprise payments platform at NACHA's PAYMENTS 2010 event at the Washington State Convention Center in Seattle.

US Dataworks Inc. (UDW) closed today at $0.2568 up 2.76 percent. Volume was 128,882.

Targacept, Inc. (TRGT)

The Street, Greenbackers, OTC Picks, and Small Cap Investor reported earlier on Targacept, Inc. (TRGT), and we choose to highlight the Company as well, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Market, Targacept, Inc. is a clinical-stage biopharmaceutical company. They discover and develop novel NNR Therapeutics™ for the treatment of central nervous system diseases and disorders. Founded in 1997, Targacept, Inc. has their headquarters in Winston-Salem, North Carolina. The Company has collaborations with AstraZeneca and with GlaxoSmithKline.

Their therapeutic focus is central nervous system diseases and disorders. Their therapeutic targets are neuronal nicotinic receptors (NNRs), which are key regulators of the nervous system.  NNRs are receptors on nerve cells that act as the "volume knobs" of the nervous system. They are throughout the brain and nervous system and they regulate and normalize brain and nervous system function. They affect memory, attention, mood, pain, inflammation, movement, and cell survival.

The Company's vision to build health and restore independence for patients has support from clinical-stage product candidates in development for major depressive disorder, attention deficit/hyperactivity disorder, Alzheimer's disease and cognitive dysfunction in schizophrenia, as well as multiple preclinical programs.

The Company's product candidates are TC-5214, major depressive disorder; AZD3480 (TC-1734), attention deficit/hyperactivity disorder (ADHD); AZD1446 (TC-6683), Alzheimer's disease; TC-5619, cognitive dysfunction in schizophrenia or one or more other indications characterized by cognitive impairment; and TC-5685, depression/anxiety disorders. For Intellectual Property, Targacept has Pentad™, a proprietary drug discovery platform, and an extensive patent estate covering compounds that act on NNRs.

Targacept has collaboration agreements with AstraZeneca AB for the development and commercialization of TC-5214 as a treatment for major depressive disorders. They also have a strategic alliance with GlaxoSmithKline. This is to discover, develop, and market product candidates that selectively target specified NNR subtypes in specified therapeutic focus areas.
In February 2010, Targacept, Inc. announced that they were awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: "Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson's Disease Biomarker."

Today, Targacept announced that they will report financial results for the first quarter ended March 31, 2010 on Wednesday, May 5, 2010, after the U.S. financial markets close.

Targacept, Inc. (TRGT) closed today's session at $24.00 up 4.58 percent. Volume was 106,876.

Seattle Genetics Inc. (SGEN)

Greenbackers, Penny Sleuth, Trading Markets, and Today's Financial News reported earlier on Seattle Genetics Inc. (SGEN), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Market, Seattle Genetics is a clinical stage biotechnology company. They focus on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. One of the cornerstones of the Company's business strategy is collaborating with leading biopharmaceutical companies. Seattle Genetics Inc. has their headquarters in Bothell, Washington.

The Company's lead product candidate is brentuximab vedotin. This is in a pivotal trial under a Special Protocol Assessment with the U.S. Food and Drug Administration. Brentuximab vedotin is undergoing development in collaboration with Millennium: The Takeda Oncology Company.

Seattle Genetics also has four other product candidates in ongoing clinical trials. These are lintuzumab (SGN-33), dacetuzumab (SGN-40), SGN-70, and SGN-75. The Company has collaborations for their ADC technology with a number of prominent biotechnology and pharmaceutical companies.

These include Bayer, Celldex Therapeutics, Daiichi Sankyo, and Genentech. They also include GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as an ADC co-development agreement with Agensys, an affiliate of Astellas.

The Company's proprietary ADC technology empowers antibodies by stably linking them to cell-killing drug payloads. The drug payload is inactive until released from the antibody inside the targeted cancer cell. Consequently, this spares normal tissue the toxicity of traditional chemotherapy.
Yesterday, Seattle Genetics Inc. reported a first-quarter profit on increased revenue from their key partner, Genentech. The Company earned $11.5 million, or 11 cents per share, compared with a loss of $27.3 million, or 33 cents per share, during the same period a year prior. Revenue grew to $46.5 million from $9.1 million. Seattle Genetics' key partnership is with Genentech, now part of Roche. The companies are developing potential cancer treatments.

Today, Seattle Genetics, Inc. announced that management will present at three upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle Genetics' website, www.seattlegenetics.com, under the "Investor and News" section. The Company will present at the Deutsche Bank Securities 35th Annual Health Care Conference, the Bank of America Merrill Lynch 2010 Health Care Conference, and the Citi 2010 Global Health Care Conference.

Seattle Genetics Inc. (SGEN) closed Wednesday's trading session at $11.93 up 5.39 percent. Volume was 762,909.

Sanswire Corp. (SNSR)

Today, Monster Stocks reported on Sanswire Corp. (SNSR), Market Wrap Daily, Stock Rich, Hot OTC, Penny Invest, Cool Penny Stocks, Bull Rally, CRWE Finance, CRWE Wall Street, and Stock Egg did yesterday. Earlier, All Penny Stocks and SmallCap Voice reported on the Company, and we report on them today, here at the QualityStocks Daily Newsletter.

Sanswire Corp. is a developer and producer of unmanned aerial vehicles (UAVs) and related technologies. The Company develops and produces patented lighter than air (LTA) UAVs with the goal of providing intelligence, surveillance, and reconnaissance (ISR) support in various applications at low, mid, and high altitudes. Sanswire Corp. trades on the OTC Bulletin Board and they have their headquarters in Aventura, Florida.

The Company's long-term goal is to develop and deliver state-of-the-art airship technology that provides surveillance sensor suites and other advanced wireless broadband capabilities to the broader commercial markets. Sanswire designs their airships and auxiliary products for use by commercial and government-related entities that require real-time intelligence, surveillance, and reconnaissance support for homeland defense, maritime, and border missions.

The Company's product lines include unique aerial vehicles focused on providing wireless communications from various altitudes, ultimately reaching the Stratosphere. Their products are all capable of unique mission specifications with various payload capacities for assorted durations.

Sanswire develops and provides an integrated suite of aerospace communications products and services. The Company takes advantage of their relationships with leaders in UAV (Unmanned Aerial Vehicle) technologies. They are currently testing various aerial vehicles, capable of carrying payloads that provide persistent surveillance and security solutions at various altitudes.

Their family of products includes the Stratellite, a Stratospheric Communications Platform, and their SAS-51, a Low Altitude Monitoring Solution. In addition, they have their SkySat, a Mid Altitude Surveillance Platform, and PADDS, a Precision Air Drop Delivery System.
Yesterday, Sanswire Corp. announced that defense contractor Global Telesat Corp. (GTC) agreed to purchase a 50 percent interest in one SkySat airship for $250,000, with an option to purchase the remaining 50 percent for an additional $750,000. Sanswire and Global Telesat intend to upgrade the airship to improve its viability for multipurpose defense and communications operations.

The two companies plan to develop a flexible platform allowing the SkySat to accommodate a range of customer requirements. Global Telesat Corp. is a leading provider of asset tracking and monitoring solutions for governments and commercial users.

Sanswire Corp.'s Chairman of the Board, Major General Wayne P. Jackson (US Army, Ret.), stated, "We are keenly focused on leveraging our existing airships and technologies to generate near-term revenue. We also are expanding our product portfolio of integrated, near-space UAV designs. Our goal is to offer a broad range of low-cost, long-duration surveillance solutions for our customers that can be delivered in a timely and cost-efficient manner."

Sanswire Corp. (SNSR) closed Wednesday's trading session at $0.0750 down 25.00 percent. Volume was 2,161,195.

The QualityStocks Company Corner

Cityside Tickets, Inc. (CIST)

The QualityStocks Daily Newsletter would like to spotlight Cityside Tickets, Inc. (CIST). Today, Cityside Tickets, Inc. closed trading at $0.0290, which was up 16.00 percent. Their volume today was 1,077,082 shares.

Cityside Tickets, Inc. (CIST) offers a diverse range of tickets for sale through their website at www.citysidetickets.com. In addition, visitors to the company’s website can use the site to sell tickets they have available. Cityside Tickets’ focus is on offering tickets to quality theatre acts in a variety of cities.

The company offers concert tickets, theatre tickets, and sports tickets to their customers. Currently, Cityside Tickets is offering concert tickets for acts such as Taylor Swift, Bon Jovi, Lady Gaga, and Elton John & Billy Joel, to name a few. For Theatre tickets, the company is offering tickets for Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, among others.

Cityside Tickets also offers tickets to Major League Baseball, NBA Basketball, NFL Football, and NHL Hockey events. They also offer Monster Jam tickets, National Finals Rodeo tickets, Ultimate Fighting Championship tickets, U.S. Open Tennis Championship tickets, and WWE-World Wrestling Entertainment tickets.

Additionally, Cityside Tickets offers tickets to NASCAR racing events. This includes tickets to the Daytona 500 at Daytona International Speedway as well as the Atlanta Motor Speedway, Darlington Raceway, Indianapolis Motor Speedway, Michigan International Speedway, Pocono Raceway, and Watkins Glen International. This is in addition to a host of other racetrack offerings presented on the company’s web portal. Disclaimer

Cityside Tickets, Inc. Blog

Cityside Tickets, Inc. News:

SectorWatch.biz: Could This be the Hottest Ticket in Town?

CitySide Tickets CEO Highlighted as a Featured Guest on MYOB Radio Show

OTC Signal Daily Stock Watch – CIST

Micro Identification Technologies Inc. (MMTC)

The QualityStocks Daily Newsletter would like to spotlight Micro Identification Technologies Inc. (MMTC) Today Micro Identification Technologies Inc. closed trading at $0.0350, for no change. Their volume today was 171,000 shares.

Micro Identification Technologies Inc. (MMTC) is focused on becoming a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. For several years the company has been working on the development of a breakthrough, laser-based microbial identification technology. This technology has been designed to be extremely fast and easy to use while not relying on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis.

The system works by measuring scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, MIT’s system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

The company’s technology offers significant advantages over today’s methods of microbial detection, including lower cost, rapid results, easier use and the ability to test for multiple bacteria in one process. The system is statistically based and includes a unique MIT Microbe Library of pre-measured light scattering identifiers - or fingerprints - derived from the measurements of tens of thousands of individual microbes for each species and subspecies to be detected.

MIT’s technology has the potential to revolutionize the $5 billion rapid microbial test market by annually saving thousands of lives and tens of millions of dollars. Since 1998, the industry has had an annual expansion of 9.2 percent - with growth projections for 30 percent annually. MIT is well positioned with its cutting-edge microbial technology as demand continues to soar as a result of major health, safety and homeland security issues. Disclaimer

Micro Identification Technologies Inc. Blog

Micro Identification Technologies Inc. News:

Micro Identification Technologies, Inc. (MMTC) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

Micro Identification Technologies Concludes a $500,000 Equity Based Private Placement

HealthNewsDigest.com Showcases Micro Identification Technologies: 'Shining a Light on Food-Borne Illnesses'

National Automation Services, Inc. (NASV) 

The QualityStocks Daily Newsletter would like to spotlight National Automation Services, Inc. (NASV). Today National Automation Services, Inc. closed trading at $0.13, for no change. Their volume today was 13,500 shares.  

National Automation Services, Inc. (NASV) is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities.  

Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 300 local and regional firms providing automation control services. In general, these companies have an edge on the larger behemoths because they can better respond to the needs of local business and municipalities.  

Unfortunately, for these smaller companies, they compete in a limited market space, have stunted growth prospects and have no way of monetizing their asset value. NAS aims to capitalize on this condition by acquiring and integrating the strongest local and regional players into a new organization that would allow for the synergies and efficiencies of a national company while keeping the competitive advantages of decentralized management and service.  

Of the 300 local and regional automation companies, 42 meet the company’s acquisition criteria; 11 of which have been targeted for acquisition over the next two years. NAS projects year-end 2010 revenues of more than $47 Million and year-end 2011 revenues of over $140 Million predicated on meeting its targeted acquisition schedule. With a solid business plan in place, NAS has a firm foundation to generate strong cash flow and increase shareholder value over the long-term. Disclaimer

National Automotion Services, Inc. Blog

National Automation Services, Inc. News:

National Automation Services, Inc. Secures Equity Financing Commitment for $5 Million

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

TOMI Environmental Solutions, Inc. (TOMZ)

The QualityStocks Daily Newsletter would like to spotlight TOMI Environmental Solutions, Inc. (TOMZ). Today, TOMI Environmental Solutions, Inc. closed trading at $0.49, for no change. Their volume today was 1,200 shares.

TOMI Environmental Solutions, Inc. (TOMZ) is focused on providing environmental services that use UV ozone, activated hydrogen peroxide and UVGI-Filtration to achieve a safe and healthy indoor environment. The company’s state of the art equipment and 3-Dimensional application inactivate viruses, remove allergens and asthma triggers, and eliminate MRSA, C-Diff, mold spores, odors, anthrax, including all other bacteria and infectious pathogens.

The target market for the company’s products and services includes hospitals, cruise ships, airlines, commercial, industrial and residential real estate, to name a few. TOMZ derives revenue through direct sale of its services; licensing its technology to remediation firms with expertise in facility restoration, disaster related damage and environmental contamination; and selling its equipment proprietary products and supplies to its licensees.

According to the American Medical Association (AMA), half of all illnesses may be caused or aggravated by poor indoor air quality. Recognizing this, TOMZ’s mission is to ensure that everyone has an opportunity to live, work and play in a healthy indoor environment. The company offers a unique suite of environmental products and services dedicated to helping consumers and organizations achieve this.

The company’s technology is deployed only by highly trained and certified technicians trained in the proper use of its products. Equipped with advanced technology, their technicians or industrial hygienists assess the air quality of commercial buildings, hospitals, schools, homes, offices, or vehicles and provide the solutions needed to eliminate allergens, asthma triggers, pathogens and contaminates. Disclaimer

TOMI Environmental Solutions, Inc. Blog

TOMI Environmental Solutions, Inc. News:

TOMI Environmental Solutions, Inc. (TOMZ) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

TOMI Environmental Solutions Announces CEO Interview

TOMI Environmental Solutions Announces CEO State of the Company Address

TOMI Environmental Solutions, Inc. (TOMZ) Follows Up On Successful Demos

TOMI Environmental Solutions Inc., a leading provider of innovative solutions for the cleaning and disinfecting of indoor air and surfaces, is following up on the positive response it received from healthcare industry leaders during recently conducted demonstrations in Atlanta. The company was in Atlanta to attend the 5th Decennial International Conference on Healthcare Associated Infections as well as the Restoration Industry Associations Annual Conference.

TOMI CEO, Dr. Halden Shane, described the interest and challenges expressed by the attendees. “Healthcare Associated Infections cost over 30 billion dollars a year. I am proud to be the CEO of a company that will be able to reduce significant costs and at the same time save lives. We were asked by remediation and healthcare industry leaders to demonstrate our state of the art air remediation and infectious disease control products. With a large international audience including hospital officials, government agencies and industry medical experts, we gathered positive feedback and left Atlanta with many requests to follow up on pertaining to our TOMI branded Green product line. According to information presented at the Healthcare Associated Infections conference, C-diff seems to be on the rise and the most difficult in eliminating from the hospital setting. Attendees were particularly interested in our Ultra-D Room Fogger, which has a 99.999% or > 6 log disinfection rate when used to disinfect a patient room or operating room.”

TOMI Environmental Solutions has developed unique and proprietary systems to safely rid indoor environments of bacteria, viruses, allergens, mold spores, odors, and dust, from both air and surfaces. It’s a service increasingly in demand for hospitals, commercial buildings, schools, homes, vehicles, and even for homeland security concerns. The strength of their products rests in their ability to penetrate even the most difficult to reach air and surface areas, while remaining safe and free of irritating by-products.

In addition to their hospital-proven Hydroxyl Ultra-D Disinfection fog used for disinfection, they have a proprietary UV Ozone Generator system, used to remove bacteria, allergens, mold spores, and even odors. There’s also a unique irradiation and filtration system which integrates with a building’s HVAC units to remove contaminates on a continuous basis. Offering a full suite of solutions, TOMI Environmental is dedicated to helping consumers and organizations achieve a healthy indoor environment.

National Automation Services, Inc. (NASV) Engages Lord & Benoit for Compliance with Sarbanes-Oxley (SOX) Act

National Automation Services, Inc., a public holding company focused on designing, engineering, installing and maintaining automated control systems, yesterday announced that it entered into a service agreement with Lord & Benoit, a consulting firm specializing in internal controls for Sarbanes-Oxley (SOX) compliance.

A pioneer in SOX 404(a) compliance since 2004 with clients worldwide, Lord & Benoit will implement a COSO Framework suitable for NAS that is not only affordable, but effective in establishing processes for: Risk Assessment, Control Environment, Control Activities, Information & Communication, and Monitoring. These components will support efforts to achieve compliance with regulatory authorities as well as NAS’ mission, strategies, and business objectives.

American Petro-Hunter, Inc. (AAPH) Set to Become 1k BOE Producer with Recent Acquisition of Working Interest in Oklahoma Prospect

American Petro-Hunter, Inc., with current production at two sites in Kansas (Poston Project in Trego County, and Rooney Project in Ford County) – and the tenacity of a mole with a nose for oil – has its sights squarely focused on closing the gap within a year to becoming a 1000 barrels of oil equivalent (BOE) producer, and toward this end has announced today further sector penetration with the acquisition of a 25% working interest in an Oklahoma-based prospect (“the Prospect”).
In exchange for 25% working interest and an 80% net revenue interest in the Prospect, AAPH has advanced $52,125 for lease acquisition and 1/4th of initial test well drilling costs, as per the requirements of the Joint Operating Agreement.

With a potential initial production well output rate of 150 barrels per day (BDP), and a sustainable multi-well (40-acre spacing) site capacity, spirits are high moving forward toward test well drilling on this Prospect located in northern OK, which should produce high-gravity light oil above 3800. Site prep work and road construction are proceeding apace, with an imminent (days) spud date (the day when drilling begins), and personnel just waiting for the rig to arrive.

Backed by strong Chinese demand, as well as other emerging markets, oil keeps trending upwards, and the declining dollar has made the crude market sweeter than ever, silencing many who have expressed concerns over relatively high supply levels.

As China sets records for oil importation (just last month again nearing records for oil consumption), infrastructural development continues unabated to sustain and drive this demand spike, creating a huge export market for domestic producers like AAPH.

The Company is dedicated to achieving laser-like focus on the goals it sets, and is firmly committed to further exploration and production growth within the industry, confident that domestic oil and gas production can provide “essential near-term” stabilization which will drive an American-made economic recovery and re-invigorate our production economy, leading to solidity within the financial system.

Barrett Business Services, Inc. (BBSI) Reports Higher Revenues in First Quarter of 2010

Barrett Business Services, Inc. reported a net loss in the first quarter of 2010 of $1.7 million, or $0.16 per diluted share. The company lost $3.2 million, or $0.30 per share, in the same quarter last year.

Barrett Business Services, Inc. said that net revenues increased on a year over year basis, from $51.1 million in the first quarter of 2009 to $58.3 million in the quarter that just ended.

Barrett Business Services, Inc. said that gross revenues, which exclude any contribution from the Professional Employer Organization segment, were $262.5 million, up from $227.8 million in the same quarter in 2009. The company excludes any revenues from the Professional Employer Organization segment because it is not the primary obligor of the services provided.

Barrett Business Services, Inc. provided guidance for the second quarter of 2010. The company said that gross revenues would range from $278-282 million, and expects diluted earnings per share to range from $0.18-0.20 per diluted share.

Barrett Business Services, Inc. ended the quarter with cash, cash equivalents and marketable securities of $43.3 million, and no long term or short term debt.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) Bacteria Wars



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336